Evidence map›Paper›PMID 15367628›Full record

ArticleJournal of virology2004

Lysines close to the Rous sarcoma virus late domain critical for budding.

Jared L Spidel, Rebecca C Craven, Carol B Wilson, Akash Patnaik, Huating Wang, Louis M Mansky, John W Wills

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Virus budding and the ESCRT pathway.Cell host & microbe · 2013
    Review
  4. Article
  5. Article
  6. How ubiquitin functions with ESCRTs.Traffic (Copenhagen, Denmark) · 2011
    Review
  7. Article
  8. Viral takeover of the host ubiquitin system.Frontiers in microbiology · 2011
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ubiquitin-dependent virus particle budding without viral protein ubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jared L SpidelDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, 500 University Dr., P.O. Box 850, Hershey, PA 17033, USA.
Rebecca C Craven
Carol B Wilson
Akash Patnaik
Huating Wang
Louis M Mansky
John W Wills
Pennsylvania State University · USThe Ohio State University · USThe Ohio State University Wexner Medical Center · US

Funding

Interactions of the CA Protein in the Retrovirus CoreR01CA100322 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CRAVEN, REBECCA C. · 2003 to 2013
$2.5M
Molecular Analysis of the Retroviral Budding MechanismR37CA047482 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WILLS, JOHN W. · 2001 to 2005
$2.4M
GAG DOMAINS REQUIRED FOR RETROVIRUS ASSEMBLYR01CA047482 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WILLS, JOHN W. · 1991 to 2000
$396k
Molecular analysis of the HTLV-1 Gag L domainR03AI053155 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MANSKY, LOUIS M · 2002 to 2003
$148k
ANALYSIS OF RETROVIRUS ASSEMBLY BY IN VITRO MUTAGENESISR29CA047482 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WILLS, JOHN W. · 1987 to 1990
–
NCI NIH HHS CA47482NCI NIH HHS R01 CA047482NCI NIH HHS R01 CA100322NCI NIH HHS R37 CA047482NIAID NIH HHS AI053155NIAID NIH HHS R03 AI053155
6 · The paper itself

Abstract

The release of retroviruses from the plasma membrane requires host factors that are believed to be recruited to the site of budding by the late (L) domain of the virus-encoded Gag protein. The L domain of Rous sarcoma virus (RSV) has been shown to interact with a ubiquitin (Ub) ligase, and budding of this virus is dependent on Ub. RSV is similar to other retroviruses in that it contains approximately 100 molecules of Ub, but it is unique in that none of these molecules has been found to be conjugated to Gag. If transient ubiquitination of RSV Gag is required for budding, then replacement of the target lysine(s) with arginine should prevent the addition of Ub and reduce budding. Based on known sites of ubiquitination in other viruses, the important lysines would likely reside near the L domain. In RSV, there are five lysines located just upstream of the L domain in a region of the matrix (MA) protein that is dispensable for membrane binding, and replacement of these with arginine (mutant 1-5KR) reduced budding 80 to 90%. The block to budding was found to be on the plasma membrane; however, the few virions that were released had normal size, morphology, and infectivity. Budding was restored when any one of the residues was changed back to lysine or when lysines were inserted in novel positions, either within this region of MA or within the downstream p10 sequence. Moreover, the 1-5KR mutant could be rescued into particles by coexpression of budding-competent Gag molecules. These data argue that the phenotype of mutant 1-5KR is not due to a conformational defect. Consistent with the idea that efficient budding requires a specific role for lysines, human T-cell leukemia virus type 1, which does not bud well compared to RSV and lacks lysines close to its L domain, was found to be released at a higher level upon introduction of lysines near its L domain. This report strongly supports the hypothesis that ubiquitination of the RSV Gag protein (and perhaps those of other retroviruses) is needed for efficient budding.

Indexed as

Amino Acid SubstitutionAnimalsAvian Sarcoma VirusesBiological TransportCell LineGene Products, gagGenetic Complementation TestHumansLysineMutagenesis, Site-DirectedMutation, MissenseProtein Structure, TertiaryUbiquitinUbiquitin-Protein LigasesViral Matrix ProteinsVirionGene Products, gagLysineUbiquitinUbiquitin-Protein LigasesViral Matrix Proteins

Identifiers

PMID15367628
PMCPMC516377
OpenAlexW2123010569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.